Histologically benign PI‐RADS 4 and 5 lesions contain cancer‐associated epigenetic alterations-Reference-Cited by-同舟云学术

Histologically benign PI‐RADS 4 and 5 lesions contain cancer‐associated epigenetic alterations

Published:2021-10-21 Issue:1 Volume:82 Page:145-153
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Şeref Ceren¹^ORCID,Acar Ömer²^ORCID,Kılıç Mert³^ORCID,Vural Metin⁴^ORCID,Sağlıcan Yeşim⁵^ORCID,Saraç Hilal¹^ORCID,Coşkun Bilgen⁴^ORCID,İnce Ümit⁵^ORCID,Esen Tarık²³^ORCID,Lack Nathan A.¹⁶⁷^ORCID

Affiliation:

1. Department of Health Sciences Koç University Research Center for Translational Medicine (KUTTAM) Istanbul Turkey

2. Department of Urology Koc University School of Medicine Istanbul Turkey

3. Department of Urology VKF American Hospital Istanbul Turkey

4. Department of Radiology VKF American Hospital Istanbul Turkey

5. Department of Pathology Acıbadem University School of Medicine Istanbul Turkey

6. Department of Medical Pharmacology Koç University School of Medicine Istanbul Turkey

7. Vancouver Prostate Centre University of British Columbia Vancouver Canada

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24255

Reference37 articles.

1. Standards for prostate biopsy

2. Comparison of Multiparametric Magnetic Resonance Imaging and Targeted Biopsy With Systematic Biopsy Alone for the Diagnosis of Prostate Cancer

3. Accuracy of Sampling PI-RADS 4–5 Index Lesions Alone by MRI-guided In-bore Biopsy in Biopsy–naive Patients Undergoing Radical Prostatectomy

4. MRI-Guided Biopsy for Prostate Cancer Detection: A Systematic Review of Current Clinical Results

5. Prostate cancer epigenetics and its clinical implications

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural history of histologically benign PIRADS 4–5 lesions in multiparametric MRI: Real‐life experience in an academic center;The Prostate;2024-06-25

2. Gene methylation status in focus of advanced prostate cancer diagnostics and improved individual outcomes;Translational Andrology and Urology;2023-12